Chemerin, a chemoattractant protein, is involved in endothelial dysfunction and 25 vascular inflammation in pathological conditions. In a recent study, we observed the 26 upregulation of chemerin in endothelial cells following in vitro treatment with T. 27 pallidum. Here, we investigated the role of chemerin in endothelial cells dysfunction 28 induced by the T. pallidum predicted membrane protein Tp0965. Following 29 stimulation of human umbilical vein endothelial cells (HUVECs) with Tp0965, 30 chemerin and its ChemR23 receptor were up-regulated, companied with elevated 31 expression of TLR2. Furthermore, chemerin from HUVECs activated endothelial cells 32 via chemerin/ChemR23 signaling in an autocrine/paracrine manner, characterized by 33 upregulated expression of ICAM-1, E-selectin and MMP-2. Activation of endothelial 34 cells depended on the MAPK signaling pathway. In addition, Tp0965-induced 35 chemerin promoted monocytes migration to endothelial cells, also via 36 chemerin/ChemR23 pathway. The RhoA/ROCK signaling pathway was also involved 37 in monocytes migration in response to chemerin/ChemR23. Our results highlight the 38 role of Tp0965-induced chemerin in endothelial cells dysfunction, which contributes to 39 the immunopathogenesis of vascular inflammation of syphilis.
performed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Briefly, cells 134 were seeded into 6-well plates and incubated with vector supernatants for 6h, and then 135 the culture medium was removed and replaced with fresh EBM-2. After an additional 136 48h culture, the cells were harvested and lysed for extraction of total RNA and protein. 137 To confirm that the transduction was successful, mRNA and protein expression levels 138 were determined by quantitative reverse transcriptase-polymerase chain reaction (qRT-139 PCR) and western blot. Sequences of the primers used in this study are listed in Table   140 1. All of the primers were designed and synthesized by Zoonbio Co. Western blot 144 Western blot analysis was performed as previously described [13] . Briefly, the total 145 protein extracted from lysed cells was electrophoresed on 10% SDS-polyacrylamide 
Results

195
Tp0965 induced expression of chemerin and ChemR23 in endothelial cells 196 To investigate the involvement of Tp0965 in expression of chemerin and ChemR23 in 197 endothelial cells, we treated HUVECs with Tp0965 or vehicle (DMSO). The level of 198 chemerin in HUVECs was elevated after stimulation using Tp0965 (Fig 1A and 1B) .
199
Likewise, expression of ChemR23 on the cell surface was significantly higher in Tp0965-treated HUVECs than in the vehicle group ( Fig 1A and 1C) . These results Tp0965 can promote activation of endothelial cells in an autocrine/paracrine manner.
228
Of the three chemerin receptors, only ChemR23 is responsible for the biological 229 activities of chemerin. To confirm that chemerin promotes activation of endothelial 230 cells through the chemerin/ChemR23 signaling pathway, we transformed HUVECs 231 with shRNA against ChemR23, denoting it as HUVECs (shChemR23). We found 232 expression of MMP-2, ICAM-1 and E-selectin in HUVECs(shChemR23) was 233 decreased by supernatants from HUVECs treated with Tp0965 ( Fig 3B) . As expected, by chemerin, we measured the phosphorylation of p-JNK, p-ERK and p38 MAPK.
239
Expression of p-ERK and p-p38 MAPK, but not p-JNK, was significantly higher in 240 HUVECs induced with supernatants from HUVECs treated with Tp0965, as well as 241 recombinant chemerin ( Fig 4A) . Next, we inhibited p-ERK and p38 MAPK with 242 SCH772984 and SB203580, respectively, before treatment with supernatant and 243 recombinant chemerin. Phosphorylation of p-ERK and p38 MAPK was inhibited by 244 these compounds ( Fig 4B) . These results suggest that the MAPK signaling pathway is 245 involved in regulating activation of HUVECs by chemerin. expression with shRNA and added these knockdown cells to the Transwell insert. THP-261 1 cells (shChemR23) were unable to migrate in response to either the supernatant or 262 recombinant chemerin. Conversely, no effect was observed with vehicle alone (Fig 5) .
263
These results formally proved that Tp0965-induced chemerin promoted monocytes 264 migration via chemerin/ChemR23 signaling pathway. activity required for monocyte migration (Fig 6B) . These data suggest that the 
325
This discrepancy may be due to difference in how chemerin protein is processed.
326
Chemerin is initially secreted as pro-chemerin, and is activated by cleavage by 327 proteases such as inflammatory serine proteases tryptase, elastase, and plasmin [43] .
328
The variant cleavages give rise to different chemerin functions, potentially explaining 329 the inconsistent results reported by previous studies.
330
In this study, we observed upregulation of ChemR23 expression in HUVECs after 331 treatment with Tp0965. ChemR23 is an orphan G protein-coupled receptor also known 332 as a chemokine-like receptor 1 (CMKLR1); the other two receptors of chemerin are 333 chemokine C-C motif receptor-like 2 (CCRL-2) and G protein-coupled receptor 1 (GPR 334 1). Among the three receptors, ChemR23 is predominantly responsible for the function 335 of chemerin in inflammation [44] . Consistent with previous research, we found that The MAPK signaling pathways have three major components: ERK, p38, and JNK.
342
These proteins exist in most immune cells and are involved in both physiological and This study has one major limitation. We showed that chemerin induced by Tp0965 
